Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.78B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
ETHA
iShares Ethereum Trust ETF
ETHA
|
+$834M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$784M |
| 5 |
Norfolk Southern
NSC
|
+$613M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$1.19B |
| 2 |
Palantir
PLTR
|
+$742M |
| 3 |
HES
Hess
HES
|
+$478M |
| 4 |
Oracle
ORCL
|
+$465M |
| 5 |
Thomson Reuters
TRI
|
+$442M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.28% |
| 2 | Financials | 7.68% |
| 3 | Healthcare | 6.5% |
| 4 | Industrials | 5.87% |
| 5 | Consumer Discretionary | 4.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3551
Cannae Holdings
CNNE
$660M
| $3.02M | ﹤0.01% |
164,707
+77,183
| +88% | +$1.53M |
|
3552
Savara
SVRA
$1.11B
| $3.01M | ﹤0.01% |
+844,177
| New | +$2.5M |
|
|
FAC
3553
Factorial Energy Inc
FAC
$633M
| $3.01M | ﹤0.01% |
300,001
+1
| +0% | +$10 |
|
3554
Red Rock Resorts
RRR
$3.76B
| $3.01M | ﹤0.01% |
49,289
-37,985
| -44% | -$2.23M |
|
3555
Jack in the Box
JACK
$329M
| $3.01M | ﹤0.01% |
152,138
+128,182
| +535% | +$2.55M |
|
3556
PUT
BrightSpring Health Services
BTSG
$12.4B
| $3.01M | ﹤0.01% |
+101,700
| New | +$2.36M |
|
3557
CALL
Bit Digital
BTBT
$492M
| $3M | ﹤0.01% |
+1,000,000
| New | +$3.03M |
|
3558
Protara Therapeutics
TARA
$225M
| $2.99M | ﹤0.01% |
688,256
+124,136
| +22% | +$402K |
|
3559
Suzano
SUZ
$10.3B
| $2.99M | ﹤0.01% |
317,983
-1,526,911
| -83% | -$14.5M |
|
|
LX
3560
LexinFintech Holdings
LX
$244M
| $2.99M | ﹤0.01% |
560,400
+380,362
| +211% | +$2.43M |
|
3561
Ultragenyx Pharmaceutical
RARE
$2.54B
| $2.98M | ﹤0.01% |
99,213
-387,128
| -80% | -$11.6M |
|
3562
Rigel Pharmaceuticals
RIGL
$716M
| $2.98M | ﹤0.01% |
105,301
+74,042
| +237% | +$2.21M |
|
3563
Covenant Logistics
CVLG
$912M
| $2.98M | ﹤0.01% |
137,486
+43,384
| +46% | +$1.04M |
|
3564
VanEck Pharmaceutical ETF
PPH
$913M
| $2.97M | ﹤0.01% |
+32,900
| New | +$2.88M |
|
3565
BWX Technologies
BWXT
$15.8B
| $2.97M | ﹤0.01% |
16,112
-12,376
| -43% | -$1.99M |
|
3566
Intrepid Potash
IPI
$456M
| $2.97M | ﹤0.01% |
97,068
+17,420
| +22% | +$548K |
|
3567
Stock Yards Bancorp
SYBT
$2.65B
| $2.97M | ﹤0.01% |
42,372
-32,731
| -44% | -$2.53M |
|
3568
CALL
XP
XP
$8.77B
| $2.97M | ﹤0.01% |
+157,800
| New | +$2.83M |
|
3569
BRC Inc
BRCC
$123M
| $2.96M | ﹤0.01% |
1,900,439
+792,458
| +72% | +$1.27M |
|
3570
Civeo
CVEO
$338M
| $2.96M | ﹤0.01% |
128,810
+88,267
| +218% | +$2.07M |
|
3571
Aclaris Therapeutics
ACRS
$835M
| $2.95M | ﹤0.01% |
1,554,458
-2,282,922
| -59% | -$3.98M |
|
|
WENNU
3572
Wen Acquisition Corp Unit
WENNU
| $2.95M | ﹤0.01% |
283,170
-399,267
| -59% | -$4.2M |
|
3573
PUT
Freshworks
FRSH
$3.33B
| $2.94M | ﹤0.01% |
+250,000
| New | +$3.37M |
|
3574
Viridian Therapeutics
VRDN
$2.3B
| $2.94M | ﹤0.01% |
136,280
+76,844
| +129% | +$1.39M |
|
3575
Main Street Capital
MAIN
$5.31B
| $2.94M | ﹤0.01% |
46,196
+31,727
| +219% | +$2.05M |
|
Similar funds
Millennium Management's Q3 2025 Portfolio in Review
As of Q3 2025, Millennium Management held 6,610 positions worth $234B, up 13% from $207B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management's Q3 2025 filing shows 800 new, 2,296 increased, 2,513 reduced and 633 closed positions. Its largest new stake was Vanguard Long-Term Corporate Bond ETF: 1,212,092 shares worth $94.1M. The largest sale was Applovin, an estimated $1.19B.
By sector, the portfolio is most concentrated in Technology at 9.3% of assets, up from 8.7% a quarter earlier, followed by Financials and Healthcare.
- Millennium Management's largest Q3 2025 buy was Vanguard Long-Term Corporate Bond ETF: 1,212,092 shares worth $94.1M.
- Millennium Management added most to NVIDIA in Q3 2025, an estimated $1.78B increase.
- Millennium Management's biggest Q3 2025 reduction was Applovin, cutting an estimated $1.19B.
- Millennium Management fully exited Hess in Q3 2025, selling an estimated $478M.
- Millennium Management's ten largest holdings make up 18% of its $234B portfolio in Q3 2025.
- Millennium Management opened 800 new positions and closed 633 in Q3 2025.
- Millennium Management's portfolio value rose 13% quarter-over-quarter to $234B.
Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.